Drug-Resistant Tuberculosis Clones Are Quietly Spreading Beyond Their Historic Heartlands

Tuberculosis remains one of humanity’s oldest and deadliest infectious diseases, yet the evolutionary story of its causative bacterium is still being written. A new genomic study published in Genome Medicine has turned a sharper light on Mycobacterium tuberculosis Lineage 3, a major human-adapted branch of the tuberculosis complex that thrives across South Asia, East Africa, and Central Asia but has long remained less well characterized than its more intensively studied relatives. By analyzing 7,472 publicly available Lineage 3 genomes drawn from 38 countries, and situating them within a global dataset of roughly 90,000 M. tuberculosis genomes, a research team led by Chendi Zhu and Weimin Li of Beijing Chest Hospital, Capital Medical University, has revealed that this lineage is far more diverse, dynamic, and drug-resistant than previously appreciated. The findings carry direct implications for how tuberculosis control programs monitor and contain resistant strains before they gain a firmer foothold in new populations.

The team began by resolving the population structure of Lineage 3 using phylogenetic reconstruction and hierarchical Bayesian clustering. This analysis showed that the dominant clade, known as L3.1.1, accounts for more than 95 percent of all Lineage 3 isolates and can be subdivided into six distinct monophyletic sublineages, designated L3.1.1.1 through L3.1.1.6. Each of these sublineages displays its own geographic distribution and demographic trajectory, meaning that what has historically been treated as a relatively uniform lineage is in fact a collection of genetically coherent populations with separate evolutionary histories. The researchers also compiled diagnostic SNP markers for each sublineage, providing a practical toolkit that other laboratories can use to classify isolates without needing to reconstruct full phylogenies for every new sample.

Phylogeographic reconstruction pointed to South Asia as the probable origin of most of the six sublineages, from which multiple intercontinental dispersal events radiated outward. This pattern fits the broader picture of tuberculosis spreading along historical human migration routes, and the study found that many European isolates were indeed associated with migration into the continent. However, the story did not end there. Using genomic clustering, terminal branch lengths, and a metric called time-scaled haplotypic density, the researchers assessed whether isolates found outside endemic regions reflected imported cases or sustained local transmission. Strikingly, they identified 1,399 isolates consistent with potential local transmission, demonstrating that Lineage 3 is not merely hitching rides with migrating populations but is, in some places, establishing self-sustaining transmission chains far from its historical range.

One of the most technically interesting aspects of the study is its use of time-scaled haplotypic density, or THD, a measure that captures how densely related genomes cluster through time and can signal recent, rapid transmission even when classical clustering criteria are ambiguous. Combined with terminal branch length analysis, which flags isolates sitting on short phylogenetic branches as likely products of recent transmission, these methods allowed the team to distinguish between the passive movement of bacteria across borders and their active amplification within new host populations. Phylodynamic modeling of effective population size through time revealed recent expansion in three sublineages in particular: L3.1.1.1, L3.1.1.5, and L3.1.1.6. These demographic signals suggest that certain branches of Lineage 3 are not just surviving outside their ancestral homelands but growing.

The drug-resistance findings are perhaps the most clinically urgent part of the work. Across the dataset, 29.8 percent of Lineage 3 isolates carried mutations associated with resistance to anti-tuberculosis drugs, a substantial burden that varies dramatically between sublineages. The highest burden was concentrated in L3.1.1.6, where 45.4 percent of isolates carried resistance-associated mutations, and where the researchers documented a marked enrichment for pre-extensively drug-resistant strains. Pre-extensively drug-resistant tuberculosis sits one step below the most intractable form of the disease, typically combining multidrug resistance with additional resistance to fluoroquinolones, and its concentration within a single expanding sublineage is a warning sign that genomic surveillance programs cannot afford to ignore.

Why should highly resistant bacteria be able to spread at all? Resistance mutations often impose a fitness cost, slowing bacterial growth and reducing transmissibility. The study offers a potential answer in the form of compensatory evolution. Within L3.1.1.6, the researchers found that compensatory mutations in the rpoA and rpoC genes, which encode subunits of the RNA polymerase complex, were associated with elevated time-scaled haplotypic density. These genes are the classic site of fitness-restoring mutations in rifampicin-resistant tuberculosis, because they can offset the cost of resistance mutations in rpoB, the primary target of the drug. The association between rpoA and rpoC compensatory mutations and higher THD values indicates that these secondary changes may be restoring the transmissibility of highly resistant clones, effectively allowing them to compete with drug-susceptible strains and facilitating their spread through populations.

Genome-wide scans for positive selection added another layer to the adaptive story. By comparing gene-wise pN/pS profiles, a measure of nonsynonymous to synonymous polymorphism that flags genes under diversifying selection, across the sublineages of Lineage 3 and against Lineages 2 and 4, the team identified signatures of adaptation that differed between geographically defined clusters. Notably, sublineage-resolved selection analyses highlighted the gene Rv1500 as consistently enriched in European local transmission clusters, suggesting that specific genetic changes may be helping the bacterium adapt to transmission in new host populations and environments. The country-specific distributions of positively selected mutations in places such as Tanzania, Norway, and Sudan further underscore how local conditions can shape the evolutionary trajectory of distinct bacterial populations.

The comparative framing of the study also matters. Lineage 2, which includes the Beijing family, and Lineage 4, the globally dominant Euro-American lineage, have been the focus of most genomic epidemiology of tuberculosis. By systematically comparing terminal branch lengths, ancestral mutation profiles, and pN/pS patterns across Lineages 2, 3, and 4, the researchers were able to place Lineage 3’s evolution in context, showing that its sublineages exhibit heterogeneous trajectories rather than a single uniform pattern of spread. This heterogeneity is the central message of the work: global dissemination of Lineage 3 is largely driven by migration, but certain sublineages show clear evidence of local amplification and expansion beyond their historical range, a distinction that only sublineage-resolved analysis can reveal.

For public health, the implications are concrete. If surveillance systems classify Lineage 3 isolates only at the lineage level, they risk missing the emergence of locally transmitting, drug-resistant clones such as those in L3.1.1.6. The diagnostic SNP markers published with this study offer a low-cost way to integrate sublineage typing into routine workflows, and the demonstration that compensatory mutations correlate with transmission potential suggests that monitoring for rpoA and rpoC changes could help prioritize which resistant clusters warrant the most aggressive public health response. As drug-resistant tuberculosis continues to challenge control efforts worldwide, studies like this one show that the fine-grained evolutionary history of bacterial populations is not an academic curiosity but a practical map of where the next outbreaks are most likely to ignite.

Subject of Research: Genomic epidemiology and evolutionary dynamics of drug-resistant Mycobacterium tuberculosis Lineage 3

Article Title: Emergence of locally transmitting and drug-resistant clones shapes global expansion of Mycobacterium tuberculosis Lineage 3

Article References: Emergence of locally transmitting and drug-resistant clones shapes global expansion of Mycobacterium tuberculosis Lineage 3. (n.d.). https://doi.org/10.1186/s13073-026-01789-6

Image Credits: AI Generated

DOI: 10.1186/s13073-026-01789-6

Keywords: Mycobacterium tuberculosis, Lineage 3, genomic epidemiology, drug resistance, phylogenetics, transmission dynamics, phylogeography, compensatory evolution, pre-extensively drug-resistant tuberculosis, rpoA, rpoC, genomic surveillance